Dr. Bryt Christensen, M.D., a pain specialist, reports, “The PGxPLUS+ pharmacogenetic test has been very helpful in my day-to-day practice. The results give insights into why some patients are not responding to medications as expected. With the help of these test results, I have been able to start or switch medications for patients more successfully. The PGxPLUS+ test helps me avoid prescribing medications that a patient won’t metabolize well, leading to better and more personalized patient care.”
Here’s his background
Training Residency: Johns Hopkins University School of Medicine – Baltimore; Physical Medicine and Rehabilitation Fellowship: Johns Hopkins University School of Medicine – Baltimore; Pain Management
This is the trouble with this board, nobody reads
Also nobody believes you or your friends own millions of shares as anyone that involved would have there homework done, obviously you don’t
Here’s all the other 28 press releases from the last 10 months as well. Might make sense for you and your “big” shareholder friends to read about what you’re pretending you own http://predtechgroup.com/press/
This takes two seconds to confirm. For millions of shares owned you took more time to type out a complaint then to just check if the company had already announced this. Just silly.
Conditional listing is board rumors. Price will be where it needs to be when it needs to be there. Literally zero concern.
News 
Market Data 
Discover 
